← Back to Analyst Consensus 
BBOT Buy
BridgeBio Oncology Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 20, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Sep 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Sep 10, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Sep 9, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Sep 9, 2026 | Raymond James | maintain | Outperform → Outperform | — | 54% |
| Sep 9, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Sep 9, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 14, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 8, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| May 11, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Mar 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 11, 2026 | Stifel | initiate | — → Buy | $23 | 53% |
| Jan 9, 2026 | Raymond James | initiate | — → Outperform | $24 | 54% |
| Dec 11, 2025 | Wedbush | reiterate | Outperform → Outperform | $25 | 58% |
| Dec 5, 2025 | Morgan Stanley | initiate | — → Overweight | $20 | 54% |
| Nov 25, 2025 | Wedbush | reiterate | Outperform → Outperform | $25 | 58% |
| Nov 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $22 | 52% |
| Sep 17, 2025 | Leerink Partners | initiate | — → Outperform | $25 | 50% |
| Sep 15, 2025 | HC Wainwright & Co. | initiate | — → Buy | $27 | 44% |
| Sep 4, 2025 | Oppenheimer | initiate | — → Outperform | $23 | 52% |
| Aug 18, 2025 | Wedbush | initiate | — → Outperform | $25 | 58% |
Price Target Trend
Apr 24, 2026 Latest: $23.55 Oct 24, 2026
EPS Estimates
+1q $-0.64
Lo: $-0.72 Hi: $-0.49
10 analysts +1y $-2.76
Lo: $-5.52 Hi: $-1.86
10 analysts ▲1
0q $-0.66
Lo: $-0.80 Hi: $-0.49
10 analysts ▲1
0y $-2.86
Lo: $-4.61 Hi: $-1.98
11 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days